Sciclone Pharmaceuticals Gets a Hold Rating from Maxim Group

By Ryan Adsit

Maxim Group analyst Gabrielle Zhou reiterated a Hold rating on Sciclone Pharmaceuticals (NASDAQ: SCLN) today. The company’s shares opened today at $10.95.

Zhou noted:

“SciCone Pharmaceuticals announced today that the company will be acquired by a China-based “buyer consortium” which includes GL Capital, Bank of China Group Investment, CDH Investments, Ascendent Capital Partners and Boying. In November 2016 the same group led by GL capital proposed similar terms. At that time the offer was considered but rejected as too low. While as analysts we see fair value at $14 we do not know precisely what changed (internally) for management to acquiesce to what appears to be essentially the same offer eight months later.”

According to TipRanks.com, Zhou is ranked 0 out of 5 stars with an average return of -13.6% and a 28.3% success rate. Zhou covers the Healthcare sector, focusing on stocks such as IntelliPharmaCeutics International, ContraVir Pharmaceuticals Inc, and Mateon Therapeutics Inc.

Sciclone Pharmaceuticals has an analyst consensus of Hold.

Based on Sciclone Pharmaceuticals’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $42.89 million and quarterly net profit of $14.6 million. In comparison, last year the company earned revenue of $36.5 million and had a net profit of $7.86 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

SciClone Pharmaceuticals, Inc. is a pharmaceutical company. It engages in the development of therapeutics treatment for oncology, infectious diseases and cardiovascular disorders. Its product includes ZADAXIN, Holoxan, Mesna, Endoxan, Farlutal, Methotrexate. Estracyt, DC Bead, Angiomax, Neucardin, Cleviprex, Loramyc, and VIBATIV. The company was founded in 1990 and is headquartered in Foster City, CA.